Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
12.93
-0.19 (-1.45%)
Dec 5, 2025, 4:00 PM EST - Market closed
Astria Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -124.03 | -94.26 | -72.89 | -51.83 | -194.91 | -37.3 | |
| Asset Writedown & Restructuring Costs | - | - | - | - | 164.61 | - | |
| Loss (Gain) From Sale of Investments | -4.03 | -5.61 | -0.09 | - | - | - | |
| Stock-Based Compensation | 15.9 | 13.04 | 6.31 | 4.55 | 3.36 | 1.39 | |
| Other Operating Activities | 1.32 | 1.07 | 0.63 | 1.1 | 0.66 | 0.06 | |
| Change in Accounts Payable | -0.14 | 2.81 | 0.73 | -0.77 | -1.97 | 0.35 | |
| Change in Other Net Operating Assets | -8.05 | 1.74 | -3.14 | 3.41 | -1.91 | 3.02 | |
| Operating Cash Flow | -119.73 | -81.21 | -68.45 | -43.53 | -30.15 | -32.49 | |
| Capital Expenditures | -0.59 | -0.33 | -0.03 | -0.09 | -0.02 | -0.03 | |
| Cash Acquisitions | - | - | - | - | 6.47 | - | |
| Investment in Securities | 135.7 | -191.54 | 135.08 | -167.04 | -19 | 6.33 | |
| Investing Cash Flow | 135.11 | -191.86 | 135.05 | -167.13 | -12.56 | 6.3 | |
| Issuance of Common Stock | 0 | 157.2 | 88.4 | 144.72 | 104.28 | 40.86 | |
| Financing Cash Flow | 0 | 157.2 | 88.4 | 144.72 | 104.28 | 40.86 | |
| Net Cash Flow | 15.38 | -115.87 | 155.01 | -65.94 | 61.58 | 14.68 | |
| Free Cash Flow | -120.32 | -81.54 | -68.47 | -43.62 | -30.17 | -32.52 | |
| Free Cash Flow Margin | -17042.92% | - | - | - | - | - | |
| Free Cash Flow Per Share | -2.07 | -1.45 | -2.27 | -2.98 | -3.38 | -10.63 | |
| Levered Free Cash Flow | -80.49 | -52.58 | -36.52 | -25.02 | -16.71 | -18.79 | |
| Unlevered Free Cash Flow | -80.49 | -52.58 | -36.52 | -25.02 | -16.71 | -18.79 | |
| Change in Working Capital | -8.89 | 4.54 | -2.41 | 2.65 | -3.88 | 3.37 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.